Autocrine role for the endothelin-B receptor in the secretion of adrenomedullin

Michihisa Jougasaki, John A. Schirger, Robert D. Simari, John C Jr. Burnett

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Adrenomedullin, originally discovered in human pheochromocytoma, is a vasodilating and natriuretic peptide of vascular endothelial and smooth muscle cell origin. Although endothelin-1 (ET-1) has been implicated as a vasoconstricting and growth-promoting peptide of endothelial origin, it may more importantly function as an autocrine factor and release vasodilatory substances such as nitric oxide by mechanisms linked to the endothelin-B (ET(B)) receptor subtype. The present study was designed to establish that the ET(B) receptor stimulates the secretion of adrenomedullin from cultured canine aortic endothelial cells. We first sought to determine the presence and production of adrenomedullin in canine aortic endothelial cells using immunohistochemistry and Northern blot analysis, which revealed that adrenomedullin immunoreactivity and adrenomedullin mRNA were present in canine aortic endothelial cells. Second, adrenomedullin was time-dependently secreted from canine aortic endothelial cells, with a secretion rate of 15.7±1.5 pg/105 cells per 24 hours. Furthermore, immunohistochemistry revealed the presence of the ET(B) receptor in canine aortic endothelial cells, and ET(B) receptor stimulation by sarafotoxin S6c increased adrenomedullin production and secretion from canine aortic endothelial cells. Such actions were blocked with the ET(B) receptor antagonist IRL-2500 but not with ET(A) receptor antagonist FR-139317. These studies are the first to report an additional autocrine role of the ET(B) receptor in the release of vasodilating and natriuretic peptide adrenomedullin, and they suggest another important vasoactive system regulated by the ET receptor subtype.

Original languageEnglish (US)
Pages (from-to)917-922
Number of pages6
JournalHypertension
Volume32
Issue number5
StatePublished - Nov 1998

Fingerprint

Endothelin B Receptors
Adrenomedullin
Canidae
Endothelial Cells
Natriuretic Peptides
Immunohistochemistry
Pheochromocytoma
Endothelin-1
Vascular Smooth Muscle
Northern Blotting
Smooth Muscle Myocytes
Nitric Oxide
Messenger RNA
Peptides

Keywords

  • Endothelium
  • Hormones
  • Immunohistochemistry
  • Peptides
  • Radioimmunoassay

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Autocrine role for the endothelin-B receptor in the secretion of adrenomedullin. / Jougasaki, Michihisa; Schirger, John A.; Simari, Robert D.; Burnett, John C Jr.

In: Hypertension, Vol. 32, No. 5, 11.1998, p. 917-922.

Research output: Contribution to journalArticle

Jougasaki, M, Schirger, JA, Simari, RD & Burnett, JCJ 1998, 'Autocrine role for the endothelin-B receptor in the secretion of adrenomedullin', Hypertension, vol. 32, no. 5, pp. 917-922.
Jougasaki, Michihisa ; Schirger, John A. ; Simari, Robert D. ; Burnett, John C Jr. / Autocrine role for the endothelin-B receptor in the secretion of adrenomedullin. In: Hypertension. 1998 ; Vol. 32, No. 5. pp. 917-922.
@article{ad9a0eba7d1f44e48826bd19450d2834,
title = "Autocrine role for the endothelin-B receptor in the secretion of adrenomedullin",
abstract = "Adrenomedullin, originally discovered in human pheochromocytoma, is a vasodilating and natriuretic peptide of vascular endothelial and smooth muscle cell origin. Although endothelin-1 (ET-1) has been implicated as a vasoconstricting and growth-promoting peptide of endothelial origin, it may more importantly function as an autocrine factor and release vasodilatory substances such as nitric oxide by mechanisms linked to the endothelin-B (ET(B)) receptor subtype. The present study was designed to establish that the ET(B) receptor stimulates the secretion of adrenomedullin from cultured canine aortic endothelial cells. We first sought to determine the presence and production of adrenomedullin in canine aortic endothelial cells using immunohistochemistry and Northern blot analysis, which revealed that adrenomedullin immunoreactivity and adrenomedullin mRNA were present in canine aortic endothelial cells. Second, adrenomedullin was time-dependently secreted from canine aortic endothelial cells, with a secretion rate of 15.7±1.5 pg/105 cells per 24 hours. Furthermore, immunohistochemistry revealed the presence of the ET(B) receptor in canine aortic endothelial cells, and ET(B) receptor stimulation by sarafotoxin S6c increased adrenomedullin production and secretion from canine aortic endothelial cells. Such actions were blocked with the ET(B) receptor antagonist IRL-2500 but not with ET(A) receptor antagonist FR-139317. These studies are the first to report an additional autocrine role of the ET(B) receptor in the release of vasodilating and natriuretic peptide adrenomedullin, and they suggest another important vasoactive system regulated by the ET receptor subtype.",
keywords = "Endothelium, Hormones, Immunohistochemistry, Peptides, Radioimmunoassay",
author = "Michihisa Jougasaki and Schirger, {John A.} and Simari, {Robert D.} and Burnett, {John C Jr.}",
year = "1998",
month = "11",
language = "English (US)",
volume = "32",
pages = "917--922",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Autocrine role for the endothelin-B receptor in the secretion of adrenomedullin

AU - Jougasaki, Michihisa

AU - Schirger, John A.

AU - Simari, Robert D.

AU - Burnett, John C Jr.

PY - 1998/11

Y1 - 1998/11

N2 - Adrenomedullin, originally discovered in human pheochromocytoma, is a vasodilating and natriuretic peptide of vascular endothelial and smooth muscle cell origin. Although endothelin-1 (ET-1) has been implicated as a vasoconstricting and growth-promoting peptide of endothelial origin, it may more importantly function as an autocrine factor and release vasodilatory substances such as nitric oxide by mechanisms linked to the endothelin-B (ET(B)) receptor subtype. The present study was designed to establish that the ET(B) receptor stimulates the secretion of adrenomedullin from cultured canine aortic endothelial cells. We first sought to determine the presence and production of adrenomedullin in canine aortic endothelial cells using immunohistochemistry and Northern blot analysis, which revealed that adrenomedullin immunoreactivity and adrenomedullin mRNA were present in canine aortic endothelial cells. Second, adrenomedullin was time-dependently secreted from canine aortic endothelial cells, with a secretion rate of 15.7±1.5 pg/105 cells per 24 hours. Furthermore, immunohistochemistry revealed the presence of the ET(B) receptor in canine aortic endothelial cells, and ET(B) receptor stimulation by sarafotoxin S6c increased adrenomedullin production and secretion from canine aortic endothelial cells. Such actions were blocked with the ET(B) receptor antagonist IRL-2500 but not with ET(A) receptor antagonist FR-139317. These studies are the first to report an additional autocrine role of the ET(B) receptor in the release of vasodilating and natriuretic peptide adrenomedullin, and they suggest another important vasoactive system regulated by the ET receptor subtype.

AB - Adrenomedullin, originally discovered in human pheochromocytoma, is a vasodilating and natriuretic peptide of vascular endothelial and smooth muscle cell origin. Although endothelin-1 (ET-1) has been implicated as a vasoconstricting and growth-promoting peptide of endothelial origin, it may more importantly function as an autocrine factor and release vasodilatory substances such as nitric oxide by mechanisms linked to the endothelin-B (ET(B)) receptor subtype. The present study was designed to establish that the ET(B) receptor stimulates the secretion of adrenomedullin from cultured canine aortic endothelial cells. We first sought to determine the presence and production of adrenomedullin in canine aortic endothelial cells using immunohistochemistry and Northern blot analysis, which revealed that adrenomedullin immunoreactivity and adrenomedullin mRNA were present in canine aortic endothelial cells. Second, adrenomedullin was time-dependently secreted from canine aortic endothelial cells, with a secretion rate of 15.7±1.5 pg/105 cells per 24 hours. Furthermore, immunohistochemistry revealed the presence of the ET(B) receptor in canine aortic endothelial cells, and ET(B) receptor stimulation by sarafotoxin S6c increased adrenomedullin production and secretion from canine aortic endothelial cells. Such actions were blocked with the ET(B) receptor antagonist IRL-2500 but not with ET(A) receptor antagonist FR-139317. These studies are the first to report an additional autocrine role of the ET(B) receptor in the release of vasodilating and natriuretic peptide adrenomedullin, and they suggest another important vasoactive system regulated by the ET receptor subtype.

KW - Endothelium

KW - Hormones

KW - Immunohistochemistry

KW - Peptides

KW - Radioimmunoassay

UR - http://www.scopus.com/inward/record.url?scp=0031739910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031739910&partnerID=8YFLogxK

M3 - Article

C2 - 9822453

AN - SCOPUS:0031739910

VL - 32

SP - 917

EP - 922

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 5

ER -